Genespire

About:

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Website: http://www.genespire.com/

Top Investors: Sofinnova Partners, CDP Venture Capital, Indaco Venture Partners, XGEN Venture

Description:

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.

Total Funding Amount:

62.6M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Milan, Lombardia, Italy

Founded Date:

2020-03-01

Contact Email:

info(AT)genespire.com

Founders:

Alessio Cantore, Luigi Naldini

Number of Employees:

1-10

Last Funding Date:

2024-09-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai